Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics in Pathological Neonatal Unconjugated Hyperbilirubinemia
NCT06449508Phase 2Not yet recruiting
- Sponsor
- Tanta University
- Start
- Jul 2024
- Primary completion
- Jun 2025
- Modality
- Microbiome Therapeutics
01
Overview
A Phase 2 trial of bacillus clausii in hyperbilirubinemia, sponsored by Tanta University. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
bacillus clausii
03
Conditions
hyperbilirubinemia
Beyond the preview
Go deeper on NCT06449508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06449508.